Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127098991 | 12709899 | 1 | I | 201406 | 20150721 | 20160902 | 20160902 | EXP | JP-GLAXOSMITHKLINE-JP2015JPN103946 | GLAXOSMITHKLINE | KIKUI S, MIYAHARA J, SUGIYAMA H, KASHIWAYA Y, TAKESHIMA T.. EFFECTIVE MICROVASCULAR DECOMPRESSION OF THE TRIGEMINAL NERVE IN A PATIENT WITH SHORT-LASTING UNILATERAL NEURALGIFORM HEADACHE ATTACKS WITH CONJUNCTIVAL. BRAIN AND NWERVE. 2016;68(8):951-955 | 43.00 | YR | M | Y | 72.00000 | KG | 20160902 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127098991 | 12709899 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 50 MG, 1D | Y | 20241 | 50 | MG | TABLET | QD | |||||
127098991 | 12709899 | 2 | SS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 100 MG, 1D | Y | 20241 | 100 | MG | TABLET | QD | |||||
127098991 | 12709899 | 3 | SS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 150 MG, 1D | Y | 20241 | 150 | MG | TABLET | QD | |||||
127098991 | 12709899 | 4 | SS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 200 MG, 1D | Y | 20241 | 200 | MG | TABLET | QD | |||||
127098991 | 12709899 | 5 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | Oral | 50 MG, 1D | Y | 0 | 50 | MG | QD | ||||||
127098991 | 12709899 | 6 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | Oral | 100 MG, 1D | Y | 0 | 100 | MG | QD | ||||||
127098991 | 12709899 | 7 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | Oral | 50 MG, 1D | Y | 0 | 50 | MG | QD | ||||||
127098991 | 12709899 | 8 | C | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | 400 MG, 1D | 0 | 400 | MG | QD | ||||||||
127098991 | 12709899 | 9 | C | GABAPENTIN. | GABAPENTIN | 1 | 1200 MG, 1D | 0 | 1200 | MG | QD | ||||||||
127098991 | 12709899 | 10 | C | GABAPENTIN. | GABAPENTIN | 1 | 1800 MG, 1D | 0 | 1800 | MG | QD | ||||||||
127098991 | 12709899 | 11 | C | SUMATRIPTAN. | SUMATRIPTAN | 1 | 3 MG, 1D | 0 | 3 | MG | QD | ||||||||
127098991 | 12709899 | 12 | C | INDOMETACIN | INDOMETHACIN | 1 | 75 MG, 1D | 0 | 75 | MG | QD | ||||||||
127098991 | 12709899 | 13 | C | LIDOCAINE. | LIDOCAINE | 1 | 2 UNK, UNK | 0 | |||||||||||
127098991 | 12709899 | 14 | C | LIDOCAINE. | LIDOCAINE | 1 | 2 UNK, UNK | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127098991 | 12709899 | HO |
127098991 | 12709899 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127098991 | 12709899 | Dermatitis bullous | |
127098991 | 12709899 | Drug eruption | |
127098991 | 12709899 | Hepatic function abnormal | |
127098991 | 12709899 | Pyrexia | |
127098991 | 12709899 | Rash pruritic | |
127098991 | 12709899 | SUNCT syndrome | |
127098991 | 12709899 | Stevens-Johnson syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127098991 | 12709899 | 1 | 201405 | 201405 | 0 | |
127098991 | 12709899 | 2 | 201405 | 201405 | 0 | |
127098991 | 12709899 | 3 | 201405 | 201406 | 0 | |
127098991 | 12709899 | 4 | 201406 | 201406 | 0 | |
127098991 | 12709899 | 5 | 201406 | 201406 | 0 | |
127098991 | 12709899 | 6 | 201406 | 201406 | 0 | |
127098991 | 12709899 | 7 | 201406 | 201412 | 0 | |
127098991 | 12709899 | 10 | 201412 | 0 | ||
127098991 | 12709899 | 11 | 201405 | 0 | ||
127098991 | 12709899 | 13 | 201405 | 201405 | 0 | |
127098991 | 12709899 | 14 | 201412 | 201412 | 0 |